# Good Clinical Practices for the Management of Cervical Dystonia with BoNT-A: A Delphi-Based Approach from the Italian Expert Group

**Authors:** Roberto Eleopra, Marcello Esposito, Anna Rita Bentivoglio, Maria Concetta Altavista, Roberto Erro, Patrizia Maria Caglioni, Anna Castagna

PMC · DOI: 10.3390/toxins18020079 · Toxins · 2026-02-02

## TL;DR

This paper presents expert-based clinical guidelines for managing cervical dystonia in Italy, aiming to standardize care and improve patient outcomes.

## Contribution

The paper introduces structured good clinical practice recommendations for cervical dystonia management based on a Delphi process involving Italian experts.

## Key findings

- A Delphi process involving 56 Italian experts achieved consensus on 52 clinical statements for cervical dystonia management.
- Recommendations include comprehensive patient assessment, individualized BoNT-A dosing, and integration of physiotherapy and psychological support.
- The guidelines aim to standardize care and optimize treatment for cervical dystonia patients.

## Abstract

Cervical dystonia (CD) is the most common adult-onset focal dystonia, with heterogeneous clinical presentation and significant functional impairment. Currently, no structured Italian good clinical practice documents specifically addressing CD have been published. Optimizing CD management requires expert-based recommendations to guide diagnosis, treatment, and follow-up. A two-round Delphi process was conducted, involving a scientific board of six neurologists with expertise in CD management and an external panel of 56 Italian experts (neurologists and physiatrists managing CD patients). Fifty-two statements were developed, discussed, and voted using a 5-point Likert scale, with consensus defined as ≥75% agreement (‘strongly agree’ or ‘somewhat agree’). In Round 1, 48 of 52 statements (92.4%) reached consensus; the four remaining statements were revised, and two were re-voted in Round 2, both achieving consensus. Final recommendations emphasize comprehensive patient assessment in multiple postural conditions; individualized botulinum neurotoxin type A (BoNT-A) dosing taking into account tonic and phasic components, pain, and dysphagia; the use of instrumental guidance; standardized outcome measures; and integration of physiotherapy and psychological support. This article provides structured good clinical practice recommendations for CD management and offers clinicians, especially those with limited experience, a practical framework to standardize care, optimize treatment, and improve patient outcomes.

## Linked entities

- **Diseases:** cervical dystonia (MONDO:0000481)

## Full-text entities

- **Diseases:** neuromuscular blockade (MESH:D020879), motor disorder (MESH:D000068079), movement disorders (MESH:D009069), basal ganglia dysfunction (MESH:D001480), Dysphagia (MESH:D003680), Tremor (MESH:D014202), disorder of impaired sensorimotor integration (MESH:D000081042), neck pain (MESH:D019547), CD (MESH:D014103), head tremor (MESH:D006258), dystonia (MESH:D004421), injury to (MESH:D014947), neurological condition (MESH:D019636), involuntary muscle contractions (MESH:C536214), muscle trophism (MESH:D019042), dystonic movements (MESH:C536300), Pain (MESH:D010146)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944977/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12944977/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944977/full.md

---
Source: https://tomesphere.com/paper/PMC12944977